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Abstract
Background: Treatment of stroke patients in stroke units has increased and studies have shown improved outcomes.
However, a large share of patients in Germany is still treated in hospitals without stroke unit. The effects of stroke unit
service line, and total hospital quality certification on outcomes remain unclear.
Methods: We employ annual hospital panel data for 1100–1300 German hospitals from 2006 to 2014, which includes
structural data and 30-day standardized mortality. We estimate hospital- and time-fixed effects regressions with three
main independent variables: (1) stroke unit care, (2) stroke unit certification, and (3) total hospital quality certification.
Results: Our results confirm the trend of decreasing stroke mortality ratios, although to a much lesser degree than
previous studies. Descriptive analysis illustrates better stroke outcomes for non-certified and certified stroke units and
hospitals with total hospital quality certification. In a fixed effects model, having a stroke unit has a significant quality-
enhancing effect, lowering stroke mortality by 5.6%, while there is no significant improvement effect for stroke unit
certification or total hospital quality certification.
Conclusions: Patients and health systems may benefit substantially from stroke unit treatment expansion as installing
a stroke unit appears more meaningful than getting it certified or obtaining a total hospital quality certification. Health
systems should thus prioritize investment in stroke unit infrastructure and centralize stroke care in stroke units. They
should also prioritize patient-based 30-day mortality data as it allows a more realistic representation of mortality than
admission-based data.
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Background
Stroke is the second-leading cause of death worldwide
[1]. Recent data shows an incidence of about 16 million
first-ever strokes annually, resulting in 5.7 million
deaths, substantial long-term disabilities and significant
long-term care costs [2]. Worldwide, the substantial
stroke incidence, associated deaths and resulting medical
and economic costs make it a truly global disease bur-
den [3, 4].
The latest OECD Health Care Quality Indicator data
suggest that admission-based mortality rates for ische-
mic stroke have decreased in the past decade, but stark
cross-country outcome differences (6-fold variation) re-
main [5]. In Germany, an analysis of admission-based
data showed an almost 20% reduction of raw and stan-
dardized mortality ratios (SMR) between 2005 and 2010.
The study’s authors concluded a possible relation to im-
proved primary and secondary prevention as well as in-
creased treatment in specialized stroke units (SUs) [6].
The latter provide specialized acute and rehabilitation
care with co-located and dedicated interdisciplinary
teams of neurologists, internists, neuro- and vascular
surgeons, and radiologists. 24/7 access to radiology (e.g.
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CT scanners) and thrombectomy equipment is also often
included. SU care has been shown to improve both
short- and long-term stroke outcomes [6–8], and reduce
overall stroke treatment cost [9, 10].
In contrast, the evidence of a positive relationship be-
tween total hospital quality (THQ) certification and out-
comes is mixed and incomplete. For stroke and acute
myocardial infarction (AMI), deliveries, and hip fractures,
a 2014 study found a positive association between certified
THQ management systems and clinical leadership, sys-
tems for patient safety, and clinical review, but not for
clinical practice [11]. Similarly, a study of the Joint Com-
mission on Accreditation of Healthcare Organization
(JCAHO) certification found risk-adjusted mortality rates
improved in a cross-section analysis of 965 hospitals in
1996 and 1997 [12]. However, most studies find a weaker
or non-existent effect between THQ and hospital out-
comes [11, 13], and a more significant effect between ser-
vice line quality systems and quality indicators (e.g. for
stroke and AMI) [7, 13, 14].
Studies with a robust fixed effect framework, large hos-
pital panel and patient-based outcome data - including for
the period after hospital discharge - are rare. Further,
while certification schemes continue to grow, the relation-
ship between certification and hospital care outcomes re-
mains inconclusive [15]. Studies have often examined the
link between certification and process measures of care,
but not the (or found only a weak) association between
certification and outcome measures of care. To our know-
ledge, no study exists that differentiates outcomes for
stroke care in a (i) conventional model, (ii) non-certified
SU model, (iii) certified SU model, and (iv) hospitals with
certified SU and/or additional THQ certification model,
based on a large patient-based panel dataset.
To examine the influence of SU infrastructure and
process specialization and certification on quality of stroke
care, we rely on Donabedian’s structure, process, and out-
come framework, in which outcomes are influenced by
hospital structures and processes [16]. Stroke care is a par-
ticularly apt example to test this relationship since SU
set-up and certification require substantial structural and
process standards to be met. Therefore, we explore
whether treatment of stroke in specialized facilities (i.e.
SUs) improves quality and thereby warrants substantial in-
vestment at hospital and health system level. Likewise, we
ask whether an additional SU certification further improves
stroke care outcomes. We also examine if THQ certifica-
tion and case volumes influence the relationship between
SU specialization, certification, and stroke outcomes.
Methods
Data
We linked hospital data from different sources based on
standardized institutional codes, which are unique mandatory
identifiers for each hospital in Germany. First, we ob-
tained structural hospital data (e.g. case volume, hos-
pital teaching status, type of ownership) for the
available years 2006, 2008, 2010, 2012, 2013, and 2014
from the German mandatory quality monitoring sys-
tem, operated by the executive authority of the German
health care system, the Federal Joint Committee
(Gemeinsamer Bundesausschuss, G-BA). The G-BA
provides publicly available hospital report cards for re-
search purposes upon request via XML files on hospital
and annual level.
Second, we integrated risk-adjusted, patient-based
stroke outcome data (for the stroke diagnoses I. intrace-
rebral hemorrhage, ICD Code I61; II. ischemic stroke,
I63, and III. stroke not specified as hemorrhage or ische-
mic, I64) from the Quality Assurance with Routine Data
(Qualitätssicherung mit Routinedaten, QSR) program.
The QSR is operated by the AOK, the largest German
sickness fund, and employs routine in- and outpatient
data of AOK insured patients. It provides a risk-adjusted
30-day SMR, comparing observed vs. expected events.
For risk-adjustment purposes, the QSR calculates 30-day
expected mortality by means of logit regressions which
includes patient-specific risk-factors like age, gender, and
a set of comorbidities [17, 18]. To ensure comparability
across years, we applied the 2014 logit risk-adjustment
model to the AOK patient data for all data years.
Third, we included information on SU certification from
the German Stroke Society (Deutsche Schlaganfall Gesell-
schaft, DSG), the premier German SU certification scheme
[19]. The data provides information on which hospitals
have DSG-certified SUs and the period of certification. A
DSG certificate, granted for three years, requires minimum
patient volume, minimum volume of certain interventions,
staff level resources, and training obligations. Hospitals with
non-certified SUs were identified by two specific procedure
codes (OPS 8-891and 8-89b), which capture provision of
complex stroke care [20].We assumed the existence of a
SU when a hospital reported at least ten such procedures
per year [6]. Structural standards are generally higher for
DSG certification than for documenting complex stroke
procedures.
Fourth, we integrated data from the THQ certificate Co-
operation for Transparency and Quality in Health Care
(Kooperation für Transparenz und Qualität im Gesund-
heitswesen, KTQ), comparable to JCAHO accreditation.
Central components include continuous quality improve-
ment in: patient orientation, employee orientation, patient
safety, quality management, communication, transpar-
ency, and leadership [21]. Like the DSG SU certificate, the
certificate is granted for 3 years. Hospital specific informa-
tion on both certification schemes were provided from the
mentioned organizations and integrated via standardized
institutional codes and address information.
Pross et al. BMC Health Services Research          (2018) 18:880 Page 2 of 8
Empirical strategy
Based on Donabedian’s quality framework [16], we
hypothesize better stroke outcome quality for hospitals
that organize care through: (ii) a dedicated SU facility, (iii)
SU certification, and (iv) total hospital quality (THQ) cer-
tification, relative to the (i) conventional, non-SU care
model. We employ a fixed effects model with a within-re-
gression estimator at hospital level. To quantify the influ-
ence of (certified) SU care on stroke outcomes, we regress
the log of stroke 30-day SMR (SMRit) on separate dummy
variables, specifying the existence of a SU (SUit), a
DSG-certified SU (acc _ SUit) and a THQ certification
(acc _THQit). We add the log of stroke case volume
(stroke _CVit) to model stroke treatment experience, and
a flattening learning curve. We include the share of stroke
patients relative to all patients treated to account for rela-
tive importance of and organizational focus on stroke
care. Hospital beds (bedsit), dummy variables for hospital
teaching status and ownership type, and a category med-
ical specialization (CMS) [22] index reflect important
time-variant characteristics. For time-variant trends that
affect each hospital equally such as technological ad-
vances, regulatory changes, and judicial decisions, we spe-
cify time effects (τt), excluding 2006 as the reference year.
To adjust for the optimal level of stroke quality of care
with a 0 SMR value (0 observed mortality), we adapt Batt-
ese’s (1997) approach to include an dummy explanatory
variable (DSMRit ), which takes on the value of 1 when the
SMR is 0, and add DSMRit to SMRit before taking the log
[23]. We further adjust for the fact that hospitals treat
variable amounts of stroke patients using AOK patient
stroke case volume as analytical weights. The main model
is specified in Eq. 1:
log SMRitð Þ¼ β0 þ β1DSMRit þ β2SUit þ β3certSUit
þβ4certTHQit þ β5 log strokeCVitð Þ
þβ6
stroke cases
all cases it
þ β7bedsit
þβ8CMSit þ β9teachit þ β10privateit
þβ11publicit þ αi þ τt þ εit
ð1Þ
In addition to the variables specified above, β0 is the
intercept, αi is individual time invariant hospital-fixed ef-
fects, and εit is the error term. To assess result robustness,
we further estimate the model using the log of the number
of SU complex procedures instead of the dummy indicator
variable for stroke units. The data comprise repeated mea-
surements at the hospital level which may involve auto-
correlation in the error term εit. A Hausman test indicates
that a random effects specification would likely yield
inconsistent estimates. We therefore use hospital fixed ef-
fects αi to control for unobserved hospital characteristics
and avoid inconsistencies. Testing the time-fixed effects τt
for joint significance indicates systematic differences in
mortality across years. All statistical inferences are based
on heteroscedasticity- and autocorrelation-consistent esti-
mates for the standard errors.
Results
Between 2006 and 2014 our sample includes on average
1243 hospitals per year (Table 1). Because of hospital
closures and mergers the number of hospitals within our
sample decreased by 13% from 1331 in 2006 to 1162 in
2014, 726 stroke-treating hospitals had no SU, 436 hos-
pitals did, of which 222 SUs were DSG-certified, and 280
hospitals were THQ-certified. On average, hospitals treat
227 stroke patients per annum and have a 30-day stroke
SMR of 0.99, a reduction of approximately 13% since
2006. In 2014, our hospital sample includes 86% of all
hospitals that recorded at least 2 stroke diagnoses. The
discrepancy (Table 1) is due to QSR data availability and
the G-BA’s 2010 shift to reporting at site level, resulting
in increases to the number of hospitals and sites in the
overall, non-QSR sample.
Figure 1 presents the weighted median and standard
deviation (SD) of the SMR for the respective hospital
sub-groups with conventional stroke care (‘No SU’), a
dedicated SU care model (‘SU’), a certified SU (‘Cert
SU’) and a certified SU within a hospital with a KTQ
THQ certificate (‘Cert SU + KTQ’).
Hospitals that treat stroke patients in a conventional
model have the highest SMR and the largest outcome
variation (i.e. SD). Their number reduces from 1047 hos-
pitals in 2006 to 721 in 2014 and their average stroke
patient volume declines from 69 to 42 patients; however,
in 2014 30,000 stroke patients are still treated at hospi-
tals with a subpar care model and a substantially higher
risk of death.
Compared to the conventional mode, the outcome
quality improves for patients treated in a stroke unit.
Both the median SMR and the outcome variation are
substantially reduced. Over time, the median SMR for
all subgroups improves, however outcome variation re-
mains roughly constant.
In 2006 and 2008, the SMR is lower in both certified
SU care models relative to the non-certified SU. How-
ever, from 2010 to 2012, the median SMR for hospitals
with a non-certified SU decreased from 1.07 to 0.98,
while for hospitals with a certified SU or both SU and
THQ certifications it increased to 1.05 and 1.03. More
than 30 larger hospitals with a relatively high 30-day
SMR received a SU certification between 2010 and 2012
and decreased their 30-day SMR, which lowered the
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Table 1 Overview main variables over time from 2006 to 2014
2006 2008 2010 2012 2013 2014
Number of hospital observationsa 1331 1292 1244 1228 1203 1162
Average 30-day stroke SMRb 1.12 1.09 1.06 1.05 1.02 0.99
Number of hospitals with SUc,d 276 337 439 414 423 436
Number of ospitals with certified SUd,e 162 189 177 211 220 222
Number of hospitals with THQ certificationd 383 434 398 360 334 280
Average stroke case volumef per hospital 167 188 202 215 219 227
Share stroke cases/inpatient cases (in %) 3.2 3.3 3.4 3.5 3.4 3.6
Numb. of hospitals with teaching status (%) 511 (38) 557 (43) 581 (47) 619 (50) 625 (52) 642 (55)
Average number of hospital beds 331 334 341 347 348 355
Average CMS specialization indexf 1.35 1.34 1.46 1.38 1.37 1.40
Number of orivate, for-profit hospitals (%) 225 (17) 237 (18) 245 (20) 257 (21) 255 (21) 255 (22)
Number of private, non-profit hospitals (%) 592 (44) 574 (44) 551 (44) 527 (43) 514 (43) 477 (41)
Number of public hospitals (%) 514 (39) 481 (37) 448 (36) 444 (36) 434 (36) 430 (37)
Number of hospitals with stroke diagnosesg 1332 1362 1329 1,37 1341 1344
aall observations that have QSR SMR stroke outcome data
bweighted by the AOK stroke patient volume for each hospital
cbased on more than 10 documented complex stroke procedures (OPS codes 8_891 und 8_89b), for 2014 461 SU exist in full sample independent on whether
QSR data is available
dand have QSR SMR stroke outcome data (especially for THQ overall more certified hospitals in Germany)
eDSG SU certification suspended in 2008 and part of 2009, which led to a backlog of (re-) certification applications and a reduction in DSG certified hospitals in
data year 2010
fbased on ICD stroke diagnoses I61 (hemorrhage), I63 (ischemic) and I64 (not further specified)
gAll hospitals which have coded 2 or more stroke ICD cases. Discrepancy in number of observations due to QSR data availability and G-BA reporting for multiple
sites starting in 2010 and becoming mandatory in 2012 and 2013
Fig. 1 Median and standard deviation (above and below median) for the 30-day stroke SMR and hospitals with a conventional care model (‘No
SU‘), a SU facility (‘SU’), a certified SU (‘Cert SU’) and a certified SU within a hospital with a KTQ THQ certificate (‘Cert SU + KTQ’). Note: 1. QSR
stroke volume applied as analytical weights; 2. Number of hospitals and associated hospital sites; 3. Mean annual stroke ICD case volume
including diagnoses I61 (hemorrhage), I63 (ischemic) and I64 (not further specified)
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overall average in the following years, but pushed up the
SMRs for the certification subgroups.
Table 2 presents descriptive statistics for the relevant
empirical model variables summing across all years.
Table 3 presents regression results of our main model
(M1). SU care is associated with a 5.6% lower 30-day
SMR, while SU or THQ certification shows no signifi-
cant additional effect on stroke outcomes. Neither stroke
volume nor the share of stroke cases relative to all in-
patient cases has a significant effect on SMR. The time
fixed effects for years 2013 and 2014 have negative and
significant coefficients (− 0.05***, − 0.08***). We consider
M1 our main model as it implements our empirical
strategy and has the lowest Bayesian Information Criter-
ion (BIC) [24].
For model robustness, we ensure consistency of our
results when using alternative variable, sample, and
model specifications M2 to M9 (see Additional file 1).
Discussion and limitations
Discussion
Our analysis confirms the positive trend over time of SMR
reduction after stroke in Germany, although to a much
lower degree than prior studies have shown [6]. This can
be attributed to the use of patient-based 30-day mortality
data, including time after patient discharge. This data en-
ables a cross-sectoral perspective on stroke care and dem-
onstrates the shortcomings of admission-based data.
The descriptive stroke SMR trends for the different
hospital sub-groups suggest progressively better stroke
outcomes in hospitals with SU infrastructure, a SU that
is also DSG-certified, and a certified SU within a THQ
certified hospital. Results of the fixed effects regression
models also show that having a SU alone significantly
enhances outcome quality of care. The results align with
previous research and confirm the benefits of treating
patients in a dedicated SU facility [7, 8, 14].
Conversely, both certifications do not show significant
effects. The structural and process differences between
non-certified and certified SUs might be too small to show
significant impact, and the overall hospital quality manage-
ment improvements associated with the THQ certification
might not be meaningful enough to influence outcomes in
emergency medical conditions such as stroke.
On a health system level, our results question why a
large share of German stroke patients is still treated in
Table 2 Descriptive statistics, all years (Mean, standard deviation,
minimum, maximum)
Mean SD Min Max
Number of observationsa (2006–2014) 7462
Average stroke 30-day SMRb 1.06 0.4 0.0 17.8
Log average stroke 30-day SMRb 0.02 0.3 −2.1 2.9
Hospitals with a specialized SU 0.31 0.5 0.0 1.0
Average complex stroke procedures 144.96 303.0 0.0 6443.0
Log average complex stroke
proceduresb
−11.83 12.3 −20.7 8.8
Hospitals with DSG-certified SU 0.16 0.4 0.0 1.0
Hospitals with KTQ-TQH certification 0.29 0.5 0.0 1.0
Average case volume stroke cases 202.17 279.0 0.0 5327.0
Log average case volume stroke
casesb
3.84 4.1 −20.7 8.6
Share stroke cases / inpatient cases 0.03 0.1 0.0 0.8
Hospitals with teaching status 0.47 0.5 0.0 1.0
Average number of hospital beds 342.23 302.0 0.0 3213.0
CMS specialization index 1.35 0.8 0.0 4.3
Private, for-profit hospitals 0.20 0.4 0.0 1.0
Private, non-for-profit hospitals 0.43 0.5 0.0 1.0
Public hospitals 0.37 0.5 0.0 1.0
aall hospitals that have QSR SMR stroke outcome data
bQSR stroke patient volume applied as analytical weights; 0.000000001 or 1
added before taking the log to avoid losing observations with 0 values, results
are similar for both
Table 3 Regression results main model M1 (beta, lower and
upper confidence interval)
M1
Log dummy −0.059* (−0.112, −0.007)
Stroke unit (SU) − 0.056** (− 0.092, − 0.021)
SU certification − 0.005 (− 0.036, − 0.026)
THQ certification 0.016 (− 0.019, 0.051)
Log stroke case volume − 0.003 (− 0.010, 0.003)
Share stroke ICD/all ICD − 0.054 (− 0.743, 0.635)
Hospital beds − 0.000 (− 0.000, 0.000)
Teaching hospital status 0.007 (− 0.041, 0.056)
CMS ICD specialization index − 0.003 (− 0.039, 0.033)
Private, for-profit hospitalsa − 0.022 (− 0.144, 0.101)
Public hospitalsa − 0.011 (− 0.138, 0.117)
Log all OPS stroke procedures –
Interaction SU and THQ certification –
Constant 0.182* (0.030, 0.333)
R2-within 0.016
R2-between 0.032
R2-overalll 0.018
BIC 1084
Intraclass correlation 0.512
F-statistic 3.9
Number of observations 7376
QSR stroke patient volume applied as analytical weights; *p < 0.05, **p < 0.01,
***p < 0.001; time-fixed effects not displayed separately (in M1, β2008 = − 0.02,
β2010 = − 0.03, β2012 = − 0.03, β2013 = − 0.05***, β2014 = − 0.08***), test for joint
significance of time effects in M1 with F-statistic of 5.59
aprivate (non-profit) hospitals serve as reference category
Pross et al. BMC Health Services Research          (2018) 18:880 Page 5 of 8
non-specialized facilities, and, related, why the shift to-
wards a centralized stroke treatment model is sluggish
[6]. Our findings suggest that treating all stroke patients
at hospitals with a SU may result in a decrease in the ab-
solute 30-day stroke mortality by 5.6%, from 16.2 to
15.3% even after adjusting for case volume and share of
stroke cases. For those roughly 50,300 stroke patients
currently treated at hospitals without SUs, this would
correspond to 460 fewer annual stroke-related deaths.
Considerable reductions in stroke-related disabilities and
in medical and economic costs are additional expected
benefits [7].
Experience in other European countries demonstrates
the positive outcome impact of stroke care centralization
in SUs [25, 26]. Underpinning the centralization argument
is the positive volume-outcome relationship, which has
also been shown to hold for stroke [27]. In the mid-term,
national and regional policy makers should ensure that all
stroke patients are treated in SUs by requiring SU infra-
structure for stroke care and centralizing stroke care with
hospitals that already operate a well-performing SU.
The German certification of SUs sets high procedural,
personnel, and infrastructural standards; however, as
above, in contrast to expectations, the SU service line
certification shows no additional significant improve-
ment with 30-day stroke SMR when non-certified SU
existence is controlled for. Several explanations are pos-
sible. First, DSG certification confirms the SU set-up ex-
ternally, with some additional staffing and process
requirements. These enhancements might not have a
large enough additional effect on the 30-day mortality
compared to the standard SU characteristics.
Second, mortality is a valid and well-accepted outcome
parameter [28], but it is only one of the outcomes that
matters in stroke care [29]. Others, such as readmis-
sions, degree of disabilities, and quality of life are also
important [7, 29]. Standardized and risk-adjusted data
for these outcome parameters are not currently available
in Germany. Certified SUs, however, might have better
outcomes for these indicators because the DSG certifica-
tion takes a holistic approach, focusing on reducing dis-
abilities after stroke [19]. Third, certified SU might have
improved outcomes over a longer timeframe than the
30 days after hospital admission examined here.
Likewise, certified SUs might provide care for more se-
vere patients, as they have on average substantially higher
case volumes (Fig. 1). While the standardized 30-day
stroke mortality is adjusted for co-morbidities, stroke se-
verity (e.g. National Institutes of Health Stroke Scale from
0 to 42) is not fully reflected by administrative data [30].
However, the impact of severity adjustment on risk-ad-
justed indicators that already are adjusted for co-morbid-
ities, age and other patient characteristics has been shown
to be limited [31]. Lastly, the suspension of the DSG SU
certification process in 2008 and first months of 2009,
which resulted in delays for about 100 re- or new stroke
unit certifications [32], might have also reduced the effect-
iveness of the DSG certification for the time span 2008–
2012 and the amount of 30-day stroke SMR improvement
attributable to the DSG certification.
THQ certification showed no additional significant ef-
fect on 30-day stroke mortality, in line with previous
studies in other countries [11, 13]. The primary purpose
of this certification is the general improvement of hos-
pital quality management; its achievement might not be
appropriately reflected by 30-day mortality in one spe-
cific emergency condition. Other measures such as pa-
tient safety, patient and employee responsiveness and
satisfaction, and operational efficiency at the hospital
level might be more affected by THQ certification. For
example, Lindlbauer et al. (2016) show improved tech-
nical efficiency for THQ-certified hospitals. A downward
bias of the THQ effect could be possible due to the fact
that no consolidated and standardized data on ISO 9001
certification, which is a universal quality certificate also
applied in hospitals, is available. Hospitals without a
KTQ certification might alternatively have an ISO 9001
THQ certification even though they appear without
THQ certification in our dataset. However, the number
of ISO 9001 certifications is likely substantially smaller
compared to the KTQ-certified hospitals [22].
Lastly, there are benefits from certification schemes
that are not captured by outcome data. Both the SU and
the THQ certification provide quality signals for pa-
tients, emergency teams, and admitting physicians,
which can facilitate hospital choice decisions.
Limitations of this study
Besides the limitations mentioned above, the results of
this study should be viewed considering some data and
methodological limitations. The validity of self-reported
hospital data might be compromised, due to reputational
concerns by hospitals and different coding practices. An-
nual, random validity checks and cross-checks with ad-
ministrative patient data, demonstrated for 5% of
hospital reports some validity issues affecting 15–60% of
the examined reporting data(26, 57).
The analyzed post-discharge timeframe of 30 days for
stroke mortality provides substantial information on out-
come quality, but an extended period like365 days might
provide additional insights. While the AOK QSR indica-
tors have some advantages, they only rely on data for pa-
tients insured by the AOK sickness fund. This might lead
to biased outcome indicators, but the high share of AOK
insured patients in all German hospitals (35% average
market share) and results from previous studies (58) dem-
onstrate the representativeness of the AOK QSR data.
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Even though the outcome data is risk-adjusted for a
large set of comorbidities and age, some bias might be
affecting the results as the outcome data is not fully ad-
justed for severity. This might especially affect certified
stroke unit hospitals as they could receive more severe
cases, also via transfer from non-certified stroke units,
leading to higher mortality that is not accounted for in
the patient-based risk adjustment. Therefore, the effect
of a SU certification or a full hospital certification is pos-
sibly underestimated in our data.
Conclusions
Our results substantiate the positive effect of SU treatment
on stroke outcomes, based on a fixed effects model and
large multi-year hospital sample, suggesting that hospital
and health system investment in SUs improve stroke out-
comes. SUs may help save numerous life-years, reduce
stroke associated disabilities, and lower long-term stroke
treatment cost considerably. Germany can learn from other
country examples regarding centralization and (mandatory)
emergency protocols for stroke treatment. As the first study
to distinguish the potential effects of SU existence, SU cer-
tification and THQ certification, we do not find a signifi-
cant effect for SU certification or THQ certification on top
of the large and significant effect for SU specialization.
Our research contributes to the literature on outcomes
and operational research and how hospital quality of
care can be improved through structural and process en-
hancements. The results have implications for the
organization of stroke care in other countries as well as
the academic and professional debate around the bene-
fits of infrastructure specialization and certification in
health care. Additional research can examine the effect
of specialization and service line certification on other
stroke outcome measures (e.g. disabilities) and outcomes
in other treatment areas, such as cardiology or oncology
specialized treatment units. Likewise, the effect of THQ
can also be examined with other outcome indicators,
with additional information on other THQ certifications
and for other more elective treatment areas, where a
THQ certification might possibly show a higher impact.
Additional file
Additional file 1: Material S1. Robustness checks. The supplementary
material S1 includes results of model specifications (M2 to M9) as
robustness checks. (DOCX 40 kb)
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